1 / 5
SJ Medical
SJ Medical
Ticagrelor is a novel, selective, and reversible P2Y12 receptor antagonist. It is a small-molecule anticoagulant primarily used as an antiplatelet agent. By inhibiting the ADP-mediated activation and aggregation of platelets, ticagrelor helps reduce the formation of blood clots and, consequently, the risk of cardiovascular events such as myocardial infarction and stroke. It is prescribed for patients with acute coronary syndrome (ACS) or those undergoing percutaneous coronary intervention (PCI) to improve cardiovascular outcomes.
| Product Name | Ticagrelor |
| Appearance | White Powder |
| Storage | Keep in a cool, dry, dark location |
| Nooglutyl | Compound 7P | Noopept, GVS-111 | Piracetam |
| Aniracetam | Nefiracetam | Pramiracetam | Fasoracetam |
| Unifiram | Sunifiram | Coluracetam | NMDA |
| Alpha GPC | CR L-40,941 | Citicoline | Galantamine |
Mature R&D Group: Continuous innovation and item improvement through accomplished development teams.
Enormous Stock: Immense stock of raw materials to satisfy requests of any size instantly.
Complete Endorsements: Comprehensive certificates including FDA, HALAL, ISO, and Organic certifications.
OEM Administration: Customized definitions and dose structures tailored to specific requirements.
Secure Bundling: All items are safely bundled to prevent pollution and ensure integrity during travel.
